Consolidated Balance Sheets (USD $)	Dec. 31, 2011	Dec. 31, 2010
Current Assets
Cash and cash equivalents	$ 12,745,432	$ 15,612,391
Short term investments	559	512
Restricted cash		3,381,369
Accounts receivable trade, net of allowance for doubtful accounts of $501,841 and $210,977, respectively	6,536,176	5,871,474
Inventory	17,153,396	21,023,388
Deferred income taxes	463,689
Prepaids and other current assets	1,711,084	993,711
Total current assets	38,610,336	46,882,845
Property, plant and equipment, net	49,363,275	36,998,241
Land use rights, net	4,872,444	4,807,834
Goodwill	19,613,470	27,002,044
Intangible assets, net	36,932,431	24,466,597
Other assets	5,935,824	2,867,188
Assets, Total	155,327,780	143,024,749
Current Liabilities
Accounts payable	10,415,342	14,286,929
Accrued liabilities	2,825,836	2,772,019
Bank loans	15,712,000	3,034,000
Notes payable	148,062	9,568,398
Mortgages payable	3,635,061
Income taxes payable	621,553	1,242,911
Deferred income taxes	651,064	232,075
Unearned revenues	2,436,532	1,708,280
Total current liabilities	36,445,450	32,844,612
Long-term Liabilities
Deferred income taxes	9,300,945	5,959,508
Deferred rent liability	1,194	45,489
Unearned revenues	169,198	282,518
Derivative liabilities	474,463	2,571,367
Acquisition-related contingent consideration	3,130,000
Amount due related parties	20,862,686	8,301,361
Total long-term liabilities	33,938,486	17,160,243
Commitments and Contingencies
Redeemable Securities
Convertible Redeemable Series E Preferred Stock; 10,582,011 shares designated, liquidation value $1.00 per share; issued and outstanding 6,662,748 and 10,582,011 shares, at December 31, 2011 and December 31, 2010, respectively	4,811,326	6,532,275
Temporary Equity, Carrying Amount, Total	4,811,326	6,532,275
Shareholders' Equity
Preferred stock; authorized, 20,000,000 shares Series B convertible redeemable preferred stock liquidation value, 1 share of common stock, $.01 par value; 825,000 shares designated; issued and outstanding, 10,000 shares at December 31, 2011 and December 31, 2010	100	100
Common stock, $.001 par value, authorized 500,000,000 shares; issued and outstanding, 109,329,587 and 64,221,130 shares, at December 31, 2011 and December 31, 2010, respectively	109,330	63,813
Additional paid-in capital	200,858,638	141,137,522
Accumulated deficit	(143,094,854)	(95,320,620)
Accumulated other comprehensive income	4,152,343	2,779,066
Total NeoStem, Inc. shareholders' equity	62,025,557	48,659,881
Noncontrolling interests	18,106,961	37,827,738
Total equity	80,132,518	86,487,619
Liabilities and Equity, Total	$ 155,327,780	$ 143,024,749